This is the final post in our “Introduction to Catapult” series on the blog. Each week we have highlighted a new Catapult topic so you can better understand this groundbreaking strategy.
To help reach our Catapult goal of advancing children’s cancer treatments out of the lab and into the clinic and commercialization, we need the right strategy and people to execute it.
Luckily, we have an amazing team of leading clinicians, scientists, industry experts and business leaders who are offering their objective expertise and thought-leadership on a pro bono basis. Many of them gathered at our Catapult Summit last February to help turn the Catapult concept into a reality.
These are the Councils and leaders that are lending a hand:
In addition to these Councils, we’ve brought together other leaders from across sectors to champion the Catapult strategy. The one thing they have in common: working together to catapult great research out of the lab and into the clinic to quickly advance better, less toxic treatments to children.
Help us advance better, less toxic treatments for children with cancer by donating toward Catapult’s lifesaving strategy. Give today so these children can survive and live longer, healthier lives tomorrow.
Want more stories like this?
Get emails that matter, when it matters.